Ruben Mesa: Discussing approaches to diversify enrollment in cancer clinical trials at ASH24
Ruben Mesa, President and Executive Director of Atrium Health Levine Cancer Institute, shared a post on LinkedIn:
“Honored to have joined Dr. Paula Aristizabal from UC San Diego Health – Moores Cancer Center at the American Society of Hematology Health Equity Studio to discuss approaches to diversify enrollment in cancer clinical trials.”
More posts featuring Ruben Mesa.
Dr. Ruben A. Mesa, MD, FACP, serves as the President and Executive Director of Atrium Health Levine Cancer Institute (LCI) and Atrium Health Wake Forest Baptist Comprehensive Cancer Center. Additionally, he holds the position of vice dean for cancer programs and professor of medicine at Wake Forest University School of Medicine.
He is an international expert in hematologic cancers, particularly myeloproliferative neoplasms (MPNs). Through his tireless efforts, Dr. Mesa continues to drive progress in the understanding and treatment of hematologic malignancies, offering hope to those affected by these complex diseases.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023